0000874015-13-000091.txt : 20130725 0000874015-13-000091.hdr.sgml : 20130725 20130725201853 ACCESSION NUMBER: 0000874015-13-000091 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130723 FILED AS OF DATE: 20130725 DATE AS OF CHANGE: 20130725 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ISIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000874015 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330336973 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 BUSINESS PHONE: 7609319200 MAIL ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CROOKE STANLEY T CENTRAL INDEX KEY: 0000897667 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19125 FILM NUMBER: 13987649 MAIL ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2013-07-23 0000874015 ISIS PHARMACEUTICALS INC ISIS 0000897667 CROOKE STANLEY T C/O ISIS PHARMACEUTICALS, INC. 2855 GAZELLE COURT CARLSBAD CA 92010 1 1 0 0 COO, President Common Stock 2013-07-23 2013-07-23 4 M 0 11500 11.12 A 13161 D Common Stock 2013-07-23 2013-07-23 4 S 0 11500 30.00 D 1661 D Common Stock 174 I By Wife Common Stock 775391 I By Trust Employee Stock Option (right to buy) 11.12 2013-07-23 2013-07-23 4 M 0 11500 0 D 2011-01-02 2014-01-01 Common Stock 11500 85355 D Acquired as a result of exercising a stock option that was scheduled to expire on 1/1/14. The purchase and sale reported on this Form 4 was effective pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on 6/27/12. /s/Stanley T. Crooke 2013-07-25